Craft

Centrexion

Total Funding

$136.1 M

Centrexion Summary

Company Summary

Overview
Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm. We aim to relieve the suffering associated with chronic pain by creating treatments that address the safety and efficacy gaps in the current treatment paradigm.
Type
Private
Status
Active
Founded
2013
HQ
Boston, MA, US | view all locations
Website
http://centrexion.com
Cybersecurity rating
Sectors

Key People

  • Jeffrey B. Kindler

    Jeffrey B. Kindler, CEO

    • James N. Campbell

      James N. Campbell, President, Chief Scientific Officer

      • Randall Stevens

        Randall Stevens, Chief Medical Officer

        • Mike Ward

          Mike Ward, Chief Financial Officer

          LocationsView all

          2 locations detected

          • Boston, MA HQ

            United States

            200 State St 6th Floor

          • Baltimore, MD

            United States

            509 S Exeter St #202

          Centrexion Financials

          Summary Financials

          Net income (FY, 2017)
          ($24.7M)
          Cash (Q3, 2018)
          $42.1M
          EBIT (FY, 2017)
          ($24.1M)

          Footer menu